A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
BackgroundHepatocellular carcinoma is one of the most common malignant tumors with a very high mortality rate. The emergence of immunotherapy has brought hope for the cure of hepatocellular carcinoma. Only a small number of patients respond to immune checkpoint inhibitors, and ferroptosis and tertia...
Main Authors: | Ye Nie, Jianhui Li, Wenlong Wu, Dongnan Guo, Xinjun Lei, Tianchen Zhang, Yanfang Wang, Zhenzhen Mao, Xuan Zhang, Wenjie Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.706915/full |
Similar Items
-
Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
by: Zhijie Xu, et al.
Published: (2021-09-01) -
Editorial: Immune Outposts on the Inflammatory Frontier: Tertiary Lymphoid Structures as Targets for Immunotherapy of Cancer and Autoimmunity
by: Karina Silina, et al.
Published: (2019-05-01) -
A Promising Esophageal Cancer Prognostic Signature of Ferroptosis-Related LncRNA to Predict Immune Scenery and Immunotherapy Response
by: Liu X, et al.
Published: (2021-09-01) -
Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters
by: Shuyue Wang, et al.
Published: (2021-07-01) -
Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy
by: Shota Aoyama, et al.
Published: (2021-05-01)